奇怪的I型干扰素在癌症中发出信号的情况
Abu Sufiyan Chhipa1, Valentina Boscaro2, Margherita Gallicchio2
1Department of Pharmacology, Institute of Pharmacy, Nirma University, 382481 Ahmedabad, India; Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.
Biochimica et biophysica acta. Reviews on cancer
|October 30, 2024
概括
干扰素-1 (IFN-1) 细胞因子在癌症中具有双重作用. 急性IFN-1信号抑制瘤,而慢性信号可以通过改变细胞通路来促进瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子信号传输的方法
背景情况:
- 细胞因子调解瘤微环境 (TME) 细胞通信.
- 干扰素-1 (IFN-1) 细胞因子表现出已知的瘤抑制机制.
- 在某些情况下,IFN-1还可以促进瘤生长.
研究的目的:
- 审查IFN-1信号传导的双重抗瘤和促瘤作用.
- 探索急性和慢性IFN-1激活如何影响TME.
- 确定利用IFN-1抗瘤潜力的策略.
主要方法:
- 在TME中对IFN-1信号的文献综述.
- 在急性和慢性IFN-1激活下下游途径改变的分析.
- 讨论针对IFN-1通路的治疗策略.
主要成果:
- 急性IFN-1信号激活表明瘤抑制功能.
- 慢性IFN-1信号激活可以导致促进瘤蛋白质的表达.
- 下游信号变化调解构成IFN-1信号的前瘤效应.
结论:
- IFN-1信号激活的背景 (急性与慢性) 决定了它在癌症中的作用.
- 了解这些双重作用对于有效的癌症治疗至关重要.
- 需要克服慢性IFN-1有害影响的策略,以利用其抗瘤益处.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


